Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency

Abstract

OBJECTIVE: Reduction of growth hormone (GH) secretion in obesity probably reflects neuroendocrine and metabolic abnormalities. Even short-term fasting stimulates GH secretion and distinguishes normal from hypopituitary subjects with growth hormone deficiency (GHD). Marked weight loss improves GH secretion in obesity but the effect of fasting is controversial. We studied the effects of a 36 h fasting on the GH/IGF-I axis and metabolic parameters in obesity.

SUBJECTS: We studied nine obese patients (OB; three male and six female; age, 29.2±4.8; range, 18–59 y; body mass index (BMI), 43.4±2.7 kg/m2; WHR, 0.9±0.1). Fifteen normal subjects (NS; eight male and seven female 28.9±0.6, 25–35 y; 21.6±0.4 kg/m2) and 10 adult hypopituitary patients with severe GH deficiency (GHD; seven male and three female; 37.6±2.3, 29–50 y; 24.5±1.0 kg/m2; GH peak<3µg/l after ITT and/or<9µg/l after GHRH+arginine) served as control groups.

STUDY DESIGN: We studied the effects of 36 h fasting on 8 h diurnal mean GH, insulin and glucose concentrations (mGHc, mINSc and mGLUc; assay every 30 min from 8.00 am to 4.00 pm) as well as on IGF-I, IGFBP-3, ALS, IGFBP-1, GHBP and free fatty acid (FFA) levels.

RESULTS: Before fasting, basal IGF-I and ALS levels in OB were similar to those in NS and both were higher (P<0.001) than those in GHD. IGFBP-3 levels in OB were lower (P<0.01) than in NS but higher (P<0.02) than in GHD. GHBP levels in OB and GHD were similar and both were higher (P<0.01) than in NS. Glucose levels were similar in all groups. FFA levels in OB were higher (P<0.01) than in NS but similar to those in GHD. IGFBP-1 in OB were lower (P<0.05) than in NS and GHD which, in turn, were similar. On the other hand, mINSc in OB was higher (P<0.01) than that in NS and GHD which, in turn, were similar. The mGHc in OB was similar to that in NS but only the latter was higher (P<0.05) than in GHD. The individual mGHc in the three groups overlapped. After fasting, IGF-I levels in GHD were unchanged while they decreased in OB (P=NS) as well as in NS (P<0.01). IGFBP-3 and ALS levels did not change. GHBP levels in OB and GHD were unchanged while they increased in NS (P<0.01). Glucose and FFA levels were reduced and increased, respectively, in all groups (P<0.02 and P<0.01). IGFBP-1 increased while mINSc decreased in all groups (P<0.02 and P<0.01); in OB they persisted lower and higher (P<0.01) respectively, than in NS and GHD. Fasting significantly increased mGHc in NS (P<0.001) but not in OB as well as in GHD. Individual mGHc in OB showed persistent overlap with GHD.

CONCLUSIONS: Short-term fasting does not increase GH secretion in obesity and does not distinguish somatotroph function in obese from that in severe GHD adults. Short-term fasting in obesity has attenuated effects on insulin and IGFBP-1 secretion while it normally increases free fatty acids in spite of any change in GH secretion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G . Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man J Clin Endocrinol Metab 1991 72: 51–59.

    Article  CAS  Google Scholar 

  2. Cordido F, Penalva A, Dieguez C, Casanueva FF . Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity J Clin Endocrinol Metab 1993 76: 819–823.

    CAS  PubMed  Google Scholar 

  3. Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E, Ghigo E . Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency Int J Obes Relat Metab Disord 1997 21: 27–32.

    Article  CAS  Google Scholar 

  4. Berelowitz M, Finkelstein JA, Thominet JL, Ting NC, Hirth J, Frohman LA . Impaired growth hormone secretion in spontaneous experimental obesity: a result of increased somatostatin (SRIF) tone 64th Annual meeting of the Endocrine Society San Antonio, TX 1983 84 (abstract 16)

    Google Scholar 

  5. Tannenbaum GS, Epelbaum J, Videau C, Dubuis JM . Sex-related alterations in hypothalamic growth hormone-releasing hormone mRNA-but not somatostatin mRNA-expressing cells in genetically obese Zucker rats Neuroendocrinology 1996 64: 186–193.

    Article  CAS  Google Scholar 

  6. Ahmad I, Finkelstein JA, Downs TR, Frohman LA . Obesity-associated decrease in growth hormone-releasing hormone gene expression: a mechanism for reduced growth hormone mRNA levels in genetically obese Zucker rats Neuroendocrinology 1993 58: 332–337.

    Article  CAS  Google Scholar 

  7. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H . Free insulin-like growth factors in human obesity Metabolism 1995 44 (10 Suppl 4): 37–44.

    Article  CAS  Google Scholar 

  8. Melmed S . Insulin suppresses growth hormone secretion by rat pituitary cells J Clin Invest 1984 73: 1425–1433.

    Article  CAS  Google Scholar 

  9. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C . Regulation of in vivo growth hormone secretion by leptin Endocrinology 1997 138: 2203–2206.

    Article  CAS  Google Scholar 

  10. Maccario M, Procopio M, Grottoli S, Oleandri SE, Boffano GM, Taliano M, Camanni F, Ghigo E . Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity Metabolism 1996 45: 342–346.

    Article  CAS  Google Scholar 

  11. Dieguez C, Carro E, Seoane LM, Garcia M, Camina JP, Senaris R, Popovic V, Casanueva FF . Regulation of somatotroph cell function by the adipose tissue Int J Obes Relat Metab Disord 2000 24 (Suppl 2): S100–S103.

    Article  CAS  Google Scholar 

  12. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO . Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man J Clin Invest 1988 81: 968–975.

    Article  CAS  Google Scholar 

  13. Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E, Thorner MO . Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men J Clin Endocrinol Metab 1992 74: 757–765.

    Article  CAS  Google Scholar 

  14. Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ . Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes Endocrinology 1991 128: 1151–1158.

    Article  CAS  Google Scholar 

  15. Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, Arvat E, Ghigo E . The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. (Review.) Int J Obes Relat Metab Disord 2000 24 (Suppl 2): S96–99.

    Article  CAS  Google Scholar 

  16. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebae NE, Hilsted J . Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects J Clin Endocrinol Metab 1995 80: 1407–1415.

    CAS  PubMed  Google Scholar 

  17. Kelijman M, Frohman LA . Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects J Clin Endocrinol Metab 1988 66: 489–495.

    Article  CAS  Google Scholar 

  18. Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E . Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine Clin Endocrinol 1995 43: 665–669.

    Article  CAS  Google Scholar 

  19. Aimaretti G, Colao A, Corneli G, Pivonello R, Maccario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E . The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults Clin Endocrinol (Oxf) 1999 51: 771–777.

    Article  CAS  Google Scholar 

  20. Carlsson LM, Rowland AM, Clark RG, Gesundheit N, Wong WL . Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood J Clin Endocrinol Metab 1991 73: 1216–1223.

    Article  CAS  Google Scholar 

  21. Pflaum CD, Dressendorfer RA, Strasburger CJ . A non isotopic solid phase immunoassay for the determination of growth hormone binding protein (hGHBP) Exp Clin Endocrinol 1993 101 (Suppl 1): 44.

    Google Scholar 

  22. Rowlinson SW, Behncken SN, Rowland JE, Clarkson RW, Strasburger CJ, Wu Z, Baumbach W, Waters MJ . Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling J Biol Chem 1998 273: 5307–5314.

    Article  CAS  Google Scholar 

  23. Riedel M, Hoeft B, Blum WF, von zur Muhlen A, Brabant G . Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction Metabolism 1995 44: 605–610.

    Article  CAS  Google Scholar 

  24. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ, Van Wyk JJ . Reduction of plasma immunoreactive somatomedin C during fasting in humans J Clin Endocrinol Metab 1981 53: 1247–1250.

    Article  CAS  Google Scholar 

  25. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OJP, Jansson JO, Ohlsson C . Liver-derived insulin-like growth factor-I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proc Natl Acad Sci 1999 96: 7088–7092.

    Article  CAS  Google Scholar 

  26. Maccario M, Tassone F, Gianotti L, Lanfranco F, Grottoli S, Arvat E, Muller EE, Ghigo E . Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity J Clin Endocrinol Metab 2001 86: 167–171.

    CAS  PubMed  Google Scholar 

  27. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KG, Thorner MO . A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans J Clin Invest 1993 91: 2453–2462.

    Article  CAS  Google Scholar 

  28. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK . Diagnosis of growth-hormone deficiency in adults Lancet 1994 343: 1064–1068.

    Article  CAS  Google Scholar 

  29. Nam SY, Lee, Kim KR, Lee HC, Nam MS, Cho JH, Huh KB . Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity Metabolism 1996 45: 594–597.

    Article  CAS  Google Scholar 

  30. Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connoly-Howard M, Tamborlane W, Sherwin RS . Suppression of counterregulatory hormone response to hypoglycemia by insulin per se J Clin Endocrinol Metab 1991 72: 1388–1390.

    Article  CAS  Google Scholar 

  31. Casanueva FF, Dieguez C . Interaction between body composition, leptin and growth hormone status Baillières Clin Endocrinol Metab 1998 12: 297–314.

    Article  CAS  Google Scholar 

  32. Alvarez CV, Mallo F, Burguera B, Cacicedo L, Dieguez C, Casanueva FF . Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat Neuroendocrinology 1991 53: 185–189.

    Article  CAS  Google Scholar 

  33. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD . Insulin regulation of insulin-like growth factor binding protein-I in obese and nonobese humans J Clin Endocrinol Metab 1992 74: 1355–1360.

    CAS  PubMed  Google Scholar 

  34. Yamashita S, Melmed S . Effect of insulin on rat anterior pituitary cells Diabetes 1986 35: 440–447.

    Article  CAS  Google Scholar 

  35. Klein S, Horowitz JF, Landt M, Goodrick SJ, Mohamed-Ali V, Coppack SW . Leptin production during early starvation in lean and obese women Am J Physiol Endocrinol Metab 2000 278: E280–284.

    Article  CAS  Google Scholar 

  36. Senaris RM, Lewis MD, Lago F, Dominguez F, Scanlon MF, Dieguez C . Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurones in monolayer culture J Mol Endocrinol 1993 10: 207–214.

    Article  CAS  Google Scholar 

  37. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF, Dieguez C . Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism J Clin Endocrinol Metab 1998 83: 4350–4354.

    CAS  PubMed  Google Scholar 

  38. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S . Effect of short-term fasting on lipid kinetics in lean and obese women Am J Physiol 1999 276: E278–284.

    CAS  PubMed  Google Scholar 

  39. Frystyk J, Delhanty PJ, Skjaerbaek C, Baxter RC . Changes in the circulating IGF system during short-term fasting and refeeding in rats Am J Physiol 1999 277: E245–252.

    CAS  PubMed  Google Scholar 

  40. Bang P, Brismar K, Rosenfeld RG, Hall K . Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects J Clin Endocrinol Metab 1994 78: 960–967.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially supported by the grant 9906153187 from Ministero Universitá e Ricerca Scientifica Tecnologica, Rome, Italy and by Fondazione Studio Malattie Endocrino-Metaboliche, Turin, Italy. The authors wish to thank Professor F Camanni and Drs C Ganzaroli, SE Oleandri, M Procopio, M Bidlingmaier, K Morrison and CD Pflaum for their cooperation in the study and S Freihofer, R Schwaiger and M Taliano for their skilful technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Ghigo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maccario, M., Aimaretti, G., Grottoli, S. et al. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes 25, 1233–1239 (2001). https://doi.org/10.1038/sj.ijo.0801671

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801671

Keywords

This article is cited by

Search

Quick links